Cardiovascular Autonomic Function After Resistance Training
ConditionSpinal Cord Injury
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age19-85
SponsorPusan National University Yangsan Hospital
About this trial
The purpose of this clinical trial is to evaluate whether an 8-week upper-limb resistance training program improves cardiovascular autonomic function in adults with chronic spinal cord injury (SCI). The primary objectives are to determine whether upper-limb resistance training improves heart rate variability (HRV) and baroreflex sensitivity (BRS), and whether it improves blood pressure responses during postural change, upper-limb strength, symptoms related to orthostatic hypotension, and quality of life.
Participants will be randomly assigned to either the resistance training group or the control group. All participants will complete assessments before and after the 8-week study period, including measurements of HRV, BRS, blood pressure responses during a tilt-table test, hand grip strength, and questionnaires assessing orthostatic hypotension symptoms and quality of life. Participants assigned to the resistance training group will participate in supervised upper-limb resistance training three times per week for 8 weeks.
Eligibility criteria
Qualifiers
Provided written informed consent and agreed to participate in the study.
Adults aged 19 to 85 years.
Chronic spinal cord injury (SCI) of traumatic or non-traumatic etiology, at least 6 months after injury.
Cervical or thoracic spinal cord injury.
Disqualifiers
Presence of any serious medical condition that would preclude participation in the study.
Inability to understand or perform the exercise program.
Uncontrolled diabetes mellitus or progressive neurological disease.
Uncontrolled hypertension (systolic blood pressure >140 mmHg or diastolic blood pressure >90 mmHg).
Trial design
Treatments tested in this trial
- Upper-Limb Resistance Training
Treatment groups
20 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov